Home > Healthcare > Medical Devices > Therapeutic Devices > Tubeless Insulin Pump Market

Tubeless Insulin Pump Market Trends

  • Report ID: GMI2032
  • Published Date: Oct 2023
  • Report Format: PDF

Tubeless Insulin Pump Market Trends

Rising technological advancements in insulin delivery devices intended to improve the comfort, safety, and overall well-being of individuals suffering from diabetes that will spur business growth. Modern tubeless insulin pumps come equipped with unique features such as advanced algorithms, an integrated continuous glucose monitoring (CGM) system, and bluetooth connectivity among others. The integration of a continuous glucose monitoring system allows users to monitor their blood glucose levels continuously and provide more accurate insulin delivery adjustments in real time, reducing the risk of hypoglycemia and hyperglycemia.

  • Moreover, tubeless insulin pumps often come equipped with bluetooth technology, enabling wireless communication with smartphones, or dedicated handheld controllers. According to the World Health Organization, about 422 million people worldwide suffer from diabetes, and 1.5 million deaths are directly attributed to diabetes each year. The rising prevalence of diabetes and related ailments propels the demand for tubeless insulin pumps.
     
  • This increasing diseased population is resulting in the adoption of more advanced tubeless that help in maintaining optimal blood glucose levels. Market players are also emphasizing the development of more technologically advanced insulin pumps. These advancements improve the overall patient experience, making it easier for clinicians to provide individualized treatment.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The tubeless insulin pump industry was valued at around USD 1.6 billion in 2022 and is projected to reach over USD 8.9 billion by the end of 2032, owing to the increasing prevalence of diabetes.

The homecare segment accounted for USD 1.2 billion in 2022 and is set to witness notable growth in the coming years, attributed to the surging adoption of tubeless insulin pumps in home care settings as well as user-friendly and easy-to-use nature of these devices.

North America market was worth USD 974 million in 2022 and is projected to reach USD 5.5 billion by 2032, pertaining to the facilitative reimbursement scenario, the high prevalence of diabetes, and the presence of major players in the region.

Insulet Corporation, Roche, Medtrum Technologies, Terumo Corporation, Mannkind Corporation, and Terumo Corporation, among others.

Tubeless Insulin Pump Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 6
  • Tables & Figures: 70
  • Countries covered: 12
  • Pages: 100
 Download Free Sample